ReP USP - Resultado da busca

Artigo de periodico
Machine learning-based virtual screening of antibacterial agents against methicillin-susceptible and resistant staphylococcus aureus (2024)
Fernandes, Philipe Oliveira ; Dias, Anna Letícia Teotonio; Santos Júnior, Valtair Severino dos ; Serafim, Mateus Sá Magalhães ; Sousa, Yamara Viana; Monteiro, Gustavo Claro ; Coutinho, Isabel Duarte ; Valli, Marilia ; Verzola, Marina Mol Sena Andrade; Ottoni, Flaviano Melo; Pádua, Rodrigo Maia de; Oda, Fernando Bombarda ; Santos, André Gonzaga dos ; Andricopulo, Adriano Defini ; Bolzani, Vanderlan da Silva ; Mota, Bruno Eduardo Fernandes; Alves, Ricardo José; Oliveira, Renata Barbosa de ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves
Source: Journal of Chemical Information and Modeling. Unidade: IFSC
Subjects: BACTÉRIAS, AGENTES ANTIMICROBIANOS, CRISTALOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Philipe Oliveira et al. Machine learning-based virtual screening of antibacterial agents against methicillin-susceptible and resistant staphylococcus aureus. Journal of Chemical Information and Modeling, v. 64, n. 6, p. 1932-1944 + supporting information, 2024Tradução . . Disponível em: https://doi.org/10.1021/acs.jcim.4c00087. Acesso em: 17 ago. 2024.
APA
Fernandes, P. O., Dias, A. L. T., Santos Júnior, V. S. dos, Serafim, M. S. M., Sousa, Y. V., Monteiro, G. C., et al. (2024). Machine learning-based virtual screening of antibacterial agents against methicillin-susceptible and resistant staphylococcus aureus. Journal of Chemical Information and Modeling, 64( 6), 1932-1944 + supporting information. doi:10.1021/acs.jcim.4c00087
NLM
Fernandes PO, Dias ALT, Santos Júnior VS dos, Serafim MSM, Sousa YV, Monteiro GC, Coutinho ID, Valli M, Verzola MMSA, Ottoni FM, Pádua RM de, Oda FB, Santos AG dos, Andricopulo AD, Bolzani V da S, Mota BEF, Alves RJ, Oliveira RB de, Kronenberger T, Maltarollo VG. Machine learning-based virtual screening of antibacterial agents against methicillin-susceptible and resistant staphylococcus aureus [Internet]. Journal of Chemical Information and Modeling. 2024 ; 64( 6): 1932-1944 + supporting information.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1021/acs.jcim.4c00087
Vancouver
Fernandes PO, Dias ALT, Santos Júnior VS dos, Serafim MSM, Sousa YV, Monteiro GC, Coutinho ID, Valli M, Verzola MMSA, Ottoni FM, Pádua RM de, Oda FB, Santos AG dos, Andricopulo AD, Bolzani V da S, Mota BEF, Alves RJ, Oliveira RB de, Kronenberger T, Maltarollo VG. Machine learning-based virtual screening of antibacterial agents against methicillin-susceptible and resistant staphylococcus aureus [Internet]. Journal of Chemical Information and Modeling. 2024 ; 64( 6): 1932-1944 + supporting information.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1021/acs.jcim.4c00087
Artigo de periodico
HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents (2024)
Waitman, Karoline de Barros ; Almeida, Larissa Costa de ; Primi, Marina Candido ; Carlos, Jorge Antonio Elias Godoy ; Ruiz, Claudia; Kronenberger, Thales ; Laufer, Stefan; Goettert, Marcia Ines; Poso, Antti ; Vassiliades, Sandra Valeria ; Souza, Vinicius Albuquerque Moreira de ; Toledo, Mônica Franco Zannini Junqueira ; Hassimotto, Neuza Mariko Aymoto ; Cameron, Michael D; Bannister, Thomas D; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho ; Tavares, Maurício T.; Parise Filho, Roberto
Source: European Journal of Medicinal Chemistry. Unidades: FCF, ICB
Subjects: ANTINEOPLÁSICOS, HIBRIDIZAÇÃO, CÉLULAS CULTIVADAS DE TUMOR, PROTEÍNAS, PURINAS, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, v. 263, p. 1-18 art. 115935, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ejmech.2023.115935. Acesso em: 17 ago. 2024.
APA
Waitman, K. de B., Almeida, L. C. de, Primi, M. C., Carlos, J. A. E. G., Ruiz, C., Kronenberger, T., et al. (2024). HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, 263, 1-18 art. 115935. doi:10.1016/j.ejmech.2023.115935
NLM
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Costa-Lotufo LV, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 ago. 17 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935
Vancouver
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Costa-Lotufo LV, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 ago. 17 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935
Artigo de periodico
Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites (2024)
Crispim, Marcell ; Verdaguer, Ignasi Bofill ; Hernández, Agustín ; Kronenberger, Thales ; Fenollar, Àngel ; Yamaguchi, Lydia Fumiko ; Alberione, María Pía ; Ramirez, Miriam; Oliveira, Sandra Souza de; Izquierdo, Luis ; Katzin, Alejandro Miguel
Source: PLoS Pathogens. Unidades: FCF, ICB
Subjects: PARASITOLOGIA, MALÁRIA, ANTIMALÁRICOS, METABÓLITOS, PROTEÍNAS QUINASES, ANIMAIS PARASITOS, PLASMODIUM FALCIPARUM, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRISPIM, Marcell et al. Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites. PLoS Pathogens, v. 20, n. 1, p. 29 , 2024Tradução . . Disponível em: https://doi.org/10.1371/journal.ppat.1011557. Acesso em: 17 ago. 2024.
APA
Crispim, M., Verdaguer, I. B., Hernández, A., Kronenberger, T., Fenollar, À., Yamaguchi, L. F., et al. (2024). Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites. PLoS Pathogens, 20( 1), 29 . doi:10.1371/journal.ppat.1011557
NLM
Crispim M, Verdaguer IB, Hernández A, Kronenberger T, Fenollar À, Yamaguchi LF, Alberione MP, Ramirez M, Oliveira SS de, Izquierdo L, Katzin AM. Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites [Internet]. PLoS Pathogens. 2024 ; 20( 1): 29 .[citado 2024 ago. 17 ] Available from: https://doi.org/10.1371/journal.ppat.1011557
Vancouver
Crispim M, Verdaguer IB, Hernández A, Kronenberger T, Fenollar À, Yamaguchi LF, Alberione MP, Ramirez M, Oliveira SS de, Izquierdo L, Katzin AM. Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites [Internet]. PLoS Pathogens. 2024 ; 20( 1): 29 .[citado 2024 ago. 17 ] Available from: https://doi.org/10.1371/journal.ppat.1011557
Artigo de periodico
MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling (2023)
Veríssimo, Gabriel Corrêa ; Simone Queiroz Panteleão; Gertrudes, Jadson Castro ; Kronenberger, Thales ; Honorio, Kathia Maria ; Maltarollo, Vinícius Gonçalves
Source: Journal of Computer - Aided Molecular Design. Unidade: EACH
Assunto: AMOSTRAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERÍSSIMO, Gabriel Corrêa et al. MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling. Journal of Computer - Aided Molecular Design, p. 01-26, 2023Tradução . . Disponível em: http://dx.doi.org/10.1007/s10822-023-00536-y. Acesso em: 17 ago. 2024.
APA
Veríssimo, G. C., Simone Queiroz Panteleão,, Gertrudes, J. C., Kronenberger, T., Honorio, K. M., & Maltarollo, V. G. (2023). MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling. Journal of Computer - Aided Molecular Design, 01-26. doi:10.1007/s10822-023-00536-y
NLM
Veríssimo GC, Simone Queiroz Panteleão, Gertrudes JC, Kronenberger T, Honorio KM, Maltarollo VG. MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling [Internet]. Journal of Computer - Aided Molecular Design. 2023 ; 01-26.[citado 2024 ago. 17 ] Available from: http://dx.doi.org/10.1007/s10822-023-00536-y
Vancouver
Veríssimo GC, Simone Queiroz Panteleão, Gertrudes JC, Kronenberger T, Honorio KM, Maltarollo VG. MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling [Internet]. Journal of Computer - Aided Molecular Design. 2023 ; 01-26.[citado 2024 ago. 17 ] Available from: http://dx.doi.org/10.1007/s10822-023-00536-y
Artigo de periodico
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors (2023)
Tavares, Maurício Temotheo ; Krüger, Arne ; Yan, Sun Liu Rei ; Waitman, Karoline de Barros ; Gomes, Vinícius de Morais ; Oliveira, Daffiny Sumam de ; Paz, Franciarli ; Hilscher, Sebastian ; Schutkowski, Mike ; Sippl, Wolfgang ; Ruiz, Claudia; Toledo, Mônica Franco Zannini Junqueira ; Poso, Antti ; Cameron, Michael D. ; Bannister, Thomas D. ; Kronenberger, Thales ; Parise Filho, Roberto ; Hassimotto, Neuza Mariko Aymoto ; Machado Neto, João Agostinho ; Palmisano, Giuseppe ; Wrenger, Carsten
Source: Scientific Reports. Unidades: FCF, ICB
Subjects: FARMACOLOGIA, PARASITOLOGIA, ANTIMALÁRICOS, EPIGÊNESE GENÉTICA, ÁCIDO FÓLICO, ANTAGONISTAS, PROTEÍNAS, PROTEÍNAS RECOMBINANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Maurício Temotheo et al. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific Reports, v. 13, n. 1, p. 20 , 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-023-47959-z. Acesso em: 17 ago. 2024.
APA
Tavares, M. T., Krüger, A., Yan, S. L. R., Waitman, K. de B., Gomes, V. de M., Oliveira, D. S. de, et al. (2023). 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific Reports, 13( 1), 20 . doi:10.1038/s41598-023-47959-z
NLM
Tavares MT, Krüger A, Yan SLR, Waitman K de B, Gomes V de M, Oliveira DS de, Paz F, Hilscher S, Schutkowski M, Sippl W, Ruiz C, Toledo MFZJ, Poso A, Cameron MD, Bannister TD, Kronenberger T, Parise Filho R, Hassimotto NMA, Machado Neto JA, Palmisano G, Wrenger C. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors [Internet]. Scientific Reports. 2023 ; 13( 1): 20 .[citado 2024 ago. 17 ] Available from: https://doi.org/10.1038/s41598-023-47959-z
Vancouver
Tavares MT, Krüger A, Yan SLR, Waitman K de B, Gomes V de M, Oliveira DS de, Paz F, Hilscher S, Schutkowski M, Sippl W, Ruiz C, Toledo MFZJ, Poso A, Cameron MD, Bannister TD, Kronenberger T, Parise Filho R, Hassimotto NMA, Machado Neto JA, Palmisano G, Wrenger C. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors [Internet]. Scientific Reports. 2023 ; 13( 1): 20 .[citado 2024 ago. 17 ] Available from: https://doi.org/10.1038/s41598-023-47959-z
Trabalho de evento-resumo
Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment (2023)
Waitman, Karoline de Barros ; Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Carlos, Jorge Antonio Elias Godoy ; Kronenberger, Thales ; Toledo, Mônica Franco Zannini Junqueira ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho ; Parise Filho, Roberto
Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química/RASBQ. Unidades: FCF, ICB
Subjects: NEOPLASIAS, HIBRIDIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. 2023, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2023. Disponível em: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf. Acesso em: 17 ago. 2024.
APA
Waitman, K. de B., Tavares, M. T., Almeida, L. C. de, Carlos, J. A. E. G., Kronenberger, T., Toledo, M. F. Z. J., et al. (2023). Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
NLM
Waitman K de B, Tavares MT, Almeida LC de, Carlos JAEG, Kronenberger T, Toledo MFZJ, Costa-Lotufo LV, Machado Neto JA, Parise Filho R. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2023 ;[citado 2024 ago. 17 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Vancouver
Waitman K de B, Tavares MT, Almeida LC de, Carlos JAEG, Kronenberger T, Toledo MFZJ, Costa-Lotufo LV, Machado Neto JA, Parise Filho R. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2023 ;[citado 2024 ago. 17 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Artigo de periodico
Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design (2023)
Ferreira, Glaucio Monteiro ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Poso, Antti ; Gatti, Fernando de Moura ; Almeida, Vitor Medeiros ; Marana, Sandro Roberto ; Lopes, Carla Duque ; Tezuka, Daiane Yukie; Albuquerque, Sérgio de ; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Pharmaceuticals. Unidades: FCF, IQ, FCFRP
Subjects: TRYPANOSOMA CRUZI, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, v. 16 , p. 1-14 art. 428, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16030428. Acesso em: 17 ago. 2024.
APA
Ferreira, G. M., Kronenberger, T., Maltarollo, V. G., Poso, A., Gatti, F. de M., Almeida, V. M., et al. (2023). Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, 16 , 1-14 art. 428. doi:10.3390/ph16030428
NLM
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3390/ph16030428
Vancouver
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3390/ph16030428
Artigo de periodico
Glycoprotein molecular dynamics analysis (2022)
Coutinho, João Victor Paccini ; Silva, Janaina Macedo da ; Mule, Simon Ngao ; Kronenberger, Thales ; Fernandes, Livia Rosa ; Wrenger, Carsten ; Palmisano, Giuseppe
Source: Advances in Protein Chemistry and Structural Biology. Unidade: ICB
Subjects: PARASITOLOGIA, GLICOPROTEÍNAS, POLISSACARÍDEOS, GLICOSAMINOGLICANAS, METABOLISMO DE PROTEÍNA, ATIVAÇÃO ENZIMÁTICA, SIMULAÇÃO DE SISTEMAS, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTINHO, João Victor Paccini et al. Glycoprotein molecular dynamics analysis. Advances in Protein Chemistry and Structural Biology, v. 131, p. 277-3091, 2022Tradução . . Disponível em: https://doi.org/10.1016/bs.apcsb.2022.05.004. Acesso em: 17 ago. 2024.
APA
Coutinho, J. V. P., Silva, J. M. da, Mule, S. N., Kronenberger, T., Fernandes, L. R., Wrenger, C., & Palmisano, G. (2022). Glycoprotein molecular dynamics analysis. Advances in Protein Chemistry and Structural Biology, 131, 277-3091. doi:10.1016/bs.apcsb.2022.05.004
NLM
Coutinho JVP, Silva JM da, Mule SN, Kronenberger T, Fernandes LR, Wrenger C, Palmisano G. Glycoprotein molecular dynamics analysis [Internet]. Advances in Protein Chemistry and Structural Biology. 2022 ; 131 277-3091.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/bs.apcsb.2022.05.004
Vancouver
Coutinho JVP, Silva JM da, Mule SN, Kronenberger T, Fernandes LR, Wrenger C, Palmisano G. Glycoprotein molecular dynamics analysis [Internet]. Advances in Protein Chemistry and Structural Biology. 2022 ; 131 277-3091.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/bs.apcsb.2022.05.004
Artigo de periodico
Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors (2021)
Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Kronenberger, Thales ; Ferreira, Glaucio Monteiro ; Divitiis, Thainá Fujii de ; Toledo, Mônica Franco Zannini Junqueira ; Hassimotto, Neuza Mariko Aymoto ; Machado Neto, João Agostinho ; Costa-Lotufo, Letícia Veras ; Parise Filho, Roberto
Source: Bioorganic and Medicinal Chemistry. Unidades: FCF, ICB, PRÓ-G
Subjects: CITOTOXICIDADE IMUNOLÓGICA, ENZIMAS, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Maurício Temotheo et al. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, v. 35, p. 1-42 art. 116085, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2021.116085. Acesso em: 17 ago. 2024.
APA
Tavares, M. T., Almeida, L. C. de, Kronenberger, T., Ferreira, G. M., Divitiis, T. F. de, Toledo, M. F. Z. J., et al. (2021). Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, 35, 1-42 art. 116085. doi:10.1016/j.bmc.2021.116085
NLM
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Costa-Lotufo LV, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085
Vancouver
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Costa-Lotufo LV, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085
Artigo de periodico
Targeting SUMOylation in plasmodium as a potential target for malaria therapy (2021)
Oliveira, Daffiny Sumam de ; Kronenberger, Thales ; Palmisano, Giuseppe ; Wrenger, Carsten ; Souza, Edmarcia Elisa de
Source: Frontiers in Cellular and Infection Microbiology. Unidade: ICB
Subjects: PARASITOLOGIA, MALÁRIA, PLASMODIUM FALCIPARUM, ANTIMALÁRICOS, ANIMAIS PARASITOS, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Daffiny Sumam de et al. Targeting SUMOylation in plasmodium as a potential target for malaria therapy. Frontiers in Cellular and Infection Microbiology, v. 11, p. 1-7, 2021Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2021.685866. Acesso em: 17 ago. 2024.
APA
Oliveira, D. S. de, Kronenberger, T., Palmisano, G., Wrenger, C., & Souza, E. E. de. (2021). Targeting SUMOylation in plasmodium as a potential target for malaria therapy. Frontiers in Cellular and Infection Microbiology, 11, 1-7. doi:10.3389/fcimb.2021.685866
NLM
Oliveira DS de, Kronenberger T, Palmisano G, Wrenger C, Souza EE de. Targeting SUMOylation in plasmodium as a potential target for malaria therapy [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-7.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3389/fcimb.2021.685866
Vancouver
Oliveira DS de, Kronenberger T, Palmisano G, Wrenger C, Souza EE de. Targeting SUMOylation in plasmodium as a potential target for malaria therapy [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-7.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3389/fcimb.2021.685866
Artigo de periodico
Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2 (2020)
Bosch, Soraya Soledad ; Lunev, Sergey ; Batista, Fernando de Assis ; Linzke, Marleen; Kronenberger, Thales ; Dömling, Alexander S. S. ; Groves, Matthew R. ; Wrenger, Carsten
Source: ACS Infectious Diseases. Unidade: ICB
Subjects: PARASITOLOGIA, COMPOSTOS ORGÂNICOS, PLASMODIUM FALCIPARUM, ASPARTATO CARBAMOILTRANSFERASE, ANIMAIS PARASITOS, MUTAÇÃO, ANTIMALÁRICOS, ATIVAÇÃO ENZIMÁTICA, MALÁRIA, ANIMAIS PARASITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOSCH, Soraya Soledad et al. Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2. ACS Infectious Diseases, v. 6. n. 5, p. 986-999, 2020Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.9b00411. Acesso em: 17 ago. 2024.
APA
Bosch, S. S., Lunev, S., Batista, F. de A., Linzke, M., Kronenberger, T., Dömling, A. S. S., et al. (2020). Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2. ACS Infectious Diseases, 6. n. 5, 986-999. doi:10.1021/acsinfecdis.9b00411
NLM
Bosch SS, Lunev S, Batista F de A, Linzke M, Kronenberger T, Dömling ASS, Groves MR, Wrenger C. Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2 [Internet]. ACS Infectious Diseases. 2020 ; 6. n. 5 986-999.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1021/acsinfecdis.9b00411
Vancouver
Bosch SS, Lunev S, Batista F de A, Linzke M, Kronenberger T, Dömling ASS, Groves MR, Wrenger C. Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2 [Internet]. ACS Infectious Diseases. 2020 ; 6. n. 5 986-999.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1021/acsinfecdis.9b00411
Artigo de periodico
QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives (2020)
Ferreira, Glaucio Monteiro; Magalhães, Juliana Gallottini de; Maltarollo, Vinícius Gonçalves; Kronenberger, Thales; Ganesan, Arasu; Emery, Flavio da Silva; Trossini, Gustavo Henrique Goulart
Source: Journal of Biomolecular Structure and Dynamics. Unidades: FCFRP, FCF
Subjects: RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives. Journal of Biomolecular Structure and Dynamics, v. 38, n. 2, p. 354-363, 2020Tradução . . Disponível em: https://doi.org/10.1080/07391102.2019.1574603. Acesso em: 17 ago. 2024.
APA
Ferreira, G. M., Magalhães, J. G. de, Maltarollo, V. G., Kronenberger, T., Ganesan, A., Emery, F. da S., & Trossini, G. H. G. (2020). QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives. Journal of Biomolecular Structure and Dynamics, 38( 2), 354-363. doi:10.1080/07391102.2019.1574603
NLM
Ferreira GM, Magalhães JG de, Maltarollo VG, Kronenberger T, Ganesan A, Emery F da S, Trossini GHG. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives [Internet]. Journal of Biomolecular Structure and Dynamics. 2020 ; 38( 2): 354-363.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1080/07391102.2019.1574603
Vancouver
Ferreira GM, Magalhães JG de, Maltarollo VG, Kronenberger T, Ganesan A, Emery F da S, Trossini GHG. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives [Internet]. Journal of Biomolecular Structure and Dynamics. 2020 ; 38( 2): 354-363.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1080/07391102.2019.1574603
Artigo de periodico
Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors (2020)
Kronenberger, Thales ; Ferreira, Glaucio Monteiro ; Souza, Alfredo Danilo Ferreira de ; Santos, Soraya da Silva; Poso, Antti ; Ribeiro, João Augusto; Tavares, Maurício Temotheo ; Pavan, Fernando Rogério ; Trossini, Gustavo Henrique Goulart ; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto
Source: Bioorganic & Medicinal Chemistry. Unidades: FCF, ICB
Subjects: MICROBIOLOGIA, METABÓLITOS, ÁCIDOS CARBOXÍLICOS, DNA, TUBERCULOSE, CINÉTICA QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, v. 28, n. 15, p. 10 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2020.115600. Acesso em: 17 ago. 2024.
APA
Kronenberger, T., Ferreira, G. M., Souza, A. D. F. de, Santos, S. da S., Poso, A., Ribeiro, J. A., et al. (2020). Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, 28( 15), 10 . doi:10.1016/j.bmc.2020.115600
NLM
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600
Vancouver
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600
Artigo de periodico
Advances with support vector machines for novel drug discovery (2019)
Maltarollo, Vinicius Gonçalves; Kronenberger, Thales; Espinoza, Gabriel Zarzana; Oliveira, Patricia Rufino; Honorio, Kathia Maria
Source: Expert Opinion on Drug Discovery. Unidade: EACH
Subjects: QUÍMICA MÉDICA, PLANEJAMENTO DE FÁRMACOS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinicius Gonçalves et al. Advances with support vector machines for novel drug discovery. Expert Opinion on Drug Discovery, v. 14, n. Ja 2019, p. 01-11, 2019Tradução . . Disponível em: https://doi.org/10.1080/17460441.2019.1549033. Acesso em: 17 ago. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Espinoza, G. Z., Oliveira, P. R., & Honorio, K. M. (2019). Advances with support vector machines for novel drug discovery. Expert Opinion on Drug Discovery, 14( Ja 2019), 01-11. doi:10.1080/17460441.2019.1549033
NLM
Maltarollo VG, Kronenberger T, Espinoza GZ, Oliveira PR, Honorio KM. Advances with support vector machines for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( Ja 2019): 01-11.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1080/17460441.2019.1549033
Vancouver
Maltarollo VG, Kronenberger T, Espinoza GZ, Oliveira PR, Honorio KM. Advances with support vector machines for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( Ja 2019): 01-11.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1080/17460441.2019.1549033
Artigo de periodico
The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation (2019)
Gao, kai ; Wang, ; Kronenberger, Thales ; Wrenger, Carsten ; Groves, Matthew
Source: Crystals. Unidade: ICB
Subjects: PARASITOLOGIA, PLASMODIUM FALCIPARUM, MALÁRIA, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GAO, kai et al. The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation. Crystals, v. 9, n. 10, p. 1-11, 2019Tradução . . Disponível em: https://doi.org/10.3390/cryst9100534. Acesso em: 17 ago. 2024.
APA
Gao, kai, Wang,, Kronenberger, T., Wrenger, C., & Groves, M. (2019). The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation. Crystals, 9( 10), 1-11. doi:10.3390/cryst9100534
NLM
Gao kai, Wang, Kronenberger T, Wrenger C, Groves M. The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation [Internet]. Crystals. 2019 ; 9( 10): 1-11.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3390/cryst9100534
Vancouver
Gao kai, Wang, Kronenberger T, Wrenger C, Groves M. The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation [Internet]. Crystals. 2019 ; 9( 10): 1-11.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3390/cryst9100534
Artigo de periodico
Molecular modeling applied to nucleic acid-based molecule development (2018)
Krüger, Arne ; Zimbres, Flávia M. ; Kronenberger, Thales ; Wrenger, Carsten
Source: Biomolecules. Unidade: ICB
Subjects: PARASITOLOGIA, ÁCIDOS NUCLEICOS, MODELAGEM MOLECULAR, MOLÉCULA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRÜGER, Arne et al. Molecular modeling applied to nucleic acid-based molecule development. Biomolecules, v. 8, n. 3, p. 1-17, 2018Tradução . . Disponível em: https://doi.org/10.3390/biom8030083. Acesso em: 17 ago. 2024.
APA
Krüger, A., Zimbres, F. M., Kronenberger, T., & Wrenger, C. (2018). Molecular modeling applied to nucleic acid-based molecule development. Biomolecules, 8( 3), 1-17. doi:10.3390/biom8030083
NLM
Krüger A, Zimbres FM, Kronenberger T, Wrenger C. Molecular modeling applied to nucleic acid-based molecule development [Internet]. Biomolecules. 2018 ; 8( 3): 1-17.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3390/biom8030083
Vancouver
Krüger A, Zimbres FM, Kronenberger T, Wrenger C. Molecular modeling applied to nucleic acid-based molecule development [Internet]. Biomolecules. 2018 ; 8( 3): 1-17.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3390/biom8030083
Artigo de periodico
Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles (2018)
Burk, Oliver; Kuzikov, Maria; Kronenberger, Thales ; Jeske, Judith; Keminer, Oliver ; Thasler, Wolfgang E. ; Schwab, Matthias ; Wrenger, Carsten ; Windshügel, Bjorn
Source: Archives of Toxicology. Unidade: ICB
Subjects: PARASITOLOGIA, ANTAGONISMO DE DROGAS, CÉLULAS KUPFFER
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURK, Oliver et al. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, v. 92, p. 1435-1451, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00204-018-2165-4. Acesso em: 17 ago. 2024.
APA
Burk, O., Kuzikov, M., Kronenberger, T., Jeske, J., Keminer, O., Thasler, W. E. , et al. (2018). Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, 92, 1435-1451. doi:10.1007/s00204-018-2165-4
NLM
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1007/s00204-018-2165-4
Vancouver
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1007/s00204-018-2165-4
Artigo de periodico
Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening (2018)
Meissner, Kamila Anna ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Trossini, Gustavo Henrique Goulart ; Wrenger, Carsten
Source: Chemical Biology and Drug Design. Unidades: FCF, ICB
Subjects: PLASMODIUM FALCIPARUM, PARASITOLOGIA, MALÁRIA, QUIMIOTERAPIA, ENZIMAS PROTEOLITICAS, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEISSNER, Kamila Anna et al. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, v. 2018 p. 1-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13416. Acesso em: 17 ago. 2024.
APA
Meissner, K. A., Kronenberger, T., Maltarollo, V. G., Trossini, G. H. G., & Wrenger, C. (2018). Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, 2018 p. 1-13. doi:10.1111/cbdd.13416
NLM
Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 ago. 17 ] Available from: https://doi.org/10.1111/cbdd.13416
Vancouver
Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 ago. 17 ] Available from: https://doi.org/10.1111/cbdd.13416
Artigo de periodico
On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity (2018)
Kronenberger, Thales ; Windshügel, Björn ; Wrenger, Carsten ; Honório, Káthia Maria ; Maltarollo, Vinícius Gonçalves
Source: Journal of Biomolecular Structure & Dynamics. Unidades: ICB, EACH
Subjects: PARASITOLOGIA, HOMEOSTASE, DOENÇAS METABÓLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity. Journal of Biomolecular Structure & Dynamics, v. 36, n. 16, p. 4378–4391, 2018Tradução . . Disponível em: https://doi.org/10.1080/07391102.2017.1417161. Acesso em: 17 ago. 2024.
APA
Kronenberger, T., Windshügel, B., Wrenger, C., Honório, K. M., & Maltarollo, V. G. (2018). On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity. Journal of Biomolecular Structure & Dynamics, 36( 16), 4378–4391. doi:10.1080/07391102.2017.1417161
NLM
Kronenberger T, Windshügel B, Wrenger C, Honório KM, Maltarollo VG. On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity [Internet]. Journal of Biomolecular Structure & Dynamics. 2018 ; 36( 16): 4378–4391.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1080/07391102.2017.1417161
Vancouver
Kronenberger T, Windshügel B, Wrenger C, Honório KM, Maltarollo VG. On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity [Internet]. Journal of Biomolecular Structure & Dynamics. 2018 ; 36( 16): 4378–4391.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1080/07391102.2017.1417161
Artigo de periodico
Advances and challenges in drug design of PPARδ ligands (2018)
Maltarollo, Vinícius Gonçalves ; Kronenberger, Thales ; Windshuegel, Bjoern ; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honório, Káthia Maria
Source: Current Drug Targets. Unidades: ICB, FCF, EACH
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, SÍNDROME X METABÓLICA, ÁCIDOS GRAXOS, DOENÇAS METABÓLICAS, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, v. 19, n. 2, p. 144-154, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389450118666170414113159. Acesso em: 17 ago. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Windshuegel, B., Wrenger, C., Trossini, G. H. G., & Honório, K. M. (2018). Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, 19( 2), 144-154. doi:10.2174/1389450118666170414113159
NLM
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 ago. 17 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Vancouver
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 ago. 17 ] Available from: https://doi.org/10.2174/1389450118666170414113159

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration